Pulling SEC filings + quote and writing the call…

Brainsway Ltd.
Next earnings Aug 11, 2026 · consensus $0.15 EPS, $50.3M rev
Mixed signals in the latest filings.
Brainsway Ltd. shows limited reported revenue.
On these fundamentals, BWAY screens as SELL on the SEC figures.
Is BWAY a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
No income data filed.
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001505065, latest 6-K filed 2026-06-29) · EODHD · as of 7/4/2026, 10:38:29 PM.
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:38 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 7 sales
| 2026-06-15 | Moiseyev Gilad Chief Technology Officer | Sell | 5.00K | |
| 2026-06-02 | Roth Yiftach Chief Scientist | Sell | 1.00K | |
| 2026-06-02 | Roth Yiftach Chief Scientist | Sell | 2.00K | |
| 2026-06-01 | Roth Yiftach Chief Scientist | Sell | 2.00K | |
| 2026-06-01 | Roth Yiftach Chief Scientist | Sell | 2.00K | |
| 2026-05-26 | Mitrany Rayten Michal Ety Director | Sell | 7.98K | |
| 2026-05-25 | Moiseyev Gilad Chief Technology Officer | Exercise | 7.50K | |
| 2026-05-25 | Moiseyev Gilad Chief Technology Officer | Tax | 1.90K | |
| 2026-05-25 | Mitrany Rayten Michal Ety Director | Sell | 10.0K | |
| 2026-05-20 | Mitrany Rayten Michal Ety Director | Exercise | 17.5K | |
| 2026-05-20 | Mitrany Rayten Michal Ety Director | Tax | 6.08K | |
| 2026-05-19 | Mitrany Rayten Michal Ety Director | Exercise | 10.0K |
| ARK Investment Management | 194K sh | $2.57M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
1195 tracked peers · median